Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products (Q36349781)

13 August 2017

1 reference

title

Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products (English)

1 reference

13 August 2017

Christopher A Ludlam

1

1 reference

PubMed ID

16371015

13 August 2017

Marc L Turner

series ordinal

2

1 reference

PubMed ID

16371015

13 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

British Journal of Haematology

13 August 2017

1 reference

13 August 2017

132

1 reference

13 August 2017

1

1 reference

13 August 2017

13-24

1 reference

vCJD tissue distribution and transmission by transfusion--a worst-case scenario coming true?

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Mammalian prion biology: one century of evolving concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Prion research: the next frontiers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Transmission dynamics and epidemiology of BSE in British cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Recipients of blood or blood products "at vCJD risk".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Proceedings of a consensus conference: the screening of blood donors for variant CJD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Epidemiological evidence of higher susceptibility to vCJD in the young

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

"Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

The cellular prion protein binds copper in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Iatrogenic Creutzfeldt-Jakob disease at the millennium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Mice devoid of PrP are resistant to scrapie

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Biology of infectious proteins: lessons from yeast prions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Levels of infectivity in the blood throughout the incubation period of hamsters peripherally injected with scrapie

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Transmissible spongiform encephalopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Prions and haemophilia: assessment of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Pathologic prion protein spreading in the peripheral nervous system of a patient with sporadic Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Removal of TSE agents from blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Hantavirus infection in the Four Corners region of USA in 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Variant Creutzfeldt-jakob disease: between lymphoid organs and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Informed consent for blood transfusion: should the possibility of prion risk be included?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Prevalence of lymphoreticular prion protein accumulation in UK tissue samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Variant Creutzfeldt-Jakob disease and its transmission by blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Epidemiological observations on spongiform encephalopathies in captive wild animals in the British Isles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee of the UKHCDO. United Kingdom Haemophilia Centre Directors' Organisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Transmission to animals of Creutzfeldt-Jakob disease from human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Complementary hydropathy identifies a cellular prion protein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

PrP protein is associated with follicular dendritic cells of spleens and lymph nodes in uninfected and scrapie-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Appropriateness and safety of blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

A novel erythroid-specific marker of transmissible spongiform encephalopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Creutzfeldt-Jakob disease (CJD) after blood product transfusion from a donor with CJD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Validation of prion removal by leucocyte-depleting filters: a cautionary tale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Leucocyte depletion of blood components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Estimation of the size of the vCJD epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Leucodepletion for transmissible spongiform encephalopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Scrapie removal using Planova virus removal filters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Purity of spiking agent affects partitioning of prions in plasma protein purification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Human prion protein with valine 129 prevents expression of variant CJD phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

A novel progressive spongiform encephalopathy in cattle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Epidemiological surveillance of Creutzfeldt-Jakob disease in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

A new variant of Creutzfeldt-Jakob disease in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Transfusion transmission of vCJD: a crisis avoided?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Naturally occurring scrapie-like spongiform encephalopathy in five domestic cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Transmission of prion diseases by blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Severely combined immunodeficient (SCID) mice resist infection with bovine spongiform encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

The same prion strain causes vCJD and BSE

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

PrP expression in B lymphocytes is not required for prion neuroinvasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

Altered circadian activity rhythms and sleep in mice devoid of prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05796.X

10.1111/J.1365-2141.2005.05796.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16371015